Skip to content
value.today
Orphazyme A/S logo

Orphazyme A/S

ORPHA.CO
$7 Mlast known market cap, Jan 2024 — no current value
Compare
World rank
—
no current market cap
Revenue
$0 M
Dec-2020 ending year
value.today research
Net income
$-101 M
value.today research
Employees
—

Orphazyme A/S in brief

Orphazyme A/S is a listed company in the Biotechnology industry, based in Denmark. Its last known market value was $7 M (January 2024); there is no current figure. In the year to Dec 2020 it had sales of $0 M and a net loss of $101 M. Its shares trade under the symbol ORPHA.CO (Copenhagen).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

Market cap history

$0 M$103 M$206 M$309 M$413 M20202021202220232024

World rank over time

▼ down 16,449 places since 2020
2020-01-01: #15364#15,36420202021-01-01: #12526#12,52620212022-01-07: #23234#23,23420222022-12-25: #32667#32,66720222023-07-30: #32519#32,51920232024-01-05: #31813#31,8132024

Rank in Denmark: #61 (Jan 2020) · #58 (Jan 2021) · #92 (Jan 2022) · #145 (Dec 2022) · #148 (Jul 2023) · #147 (Jan 2024)

Annual results

Revenue
$0 M
Operating income
—
Net income
$-101 M

Dec-2020 ending year

How Orphazyme A/S compares in Biotechnology

  • Revenue$0 M · higher than 0% of 647

Peer comparison · Biotechnology

CompanyMarket capP/ENet marginRev. growth
Orphazyme A/S🇩🇰$7 M———
Novo Nordisk A/S🇩🇰$203.2 B13.1×33.1%+10.8%
Vertex Pharmaceuticals Incorporated🇺🇸$134.3 B33.8×30.7%+8.9%
Moderna, Inc.🇺🇸$90.1 B—-110.5%-39.9%
Regeneron Pharmaceuticals, Inc.🇺🇸$84.1 B17.5×28.5%+1.0%
Argenx SE🇳🇱$52.8 B40.9×31.1%+89.9%
CSL Limited🇦🇺$51.6 B—-16.4%—
Samsung Biologics Co., Ltd.🇰🇷$51.5 B40.5×39.2%—
UCB SA🇧🇪$48.6 B26.3×20.1%+31.1%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Jan 5, 2024 (last known)
Annual results:
Dec-2020 ending year
Balance sheet:
Dec-2020 ending year
Profile updated:
Nov 15, 2026

Figures from value.today research.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Orphazyme A/S? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Orphazyme A/S's ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Orphazyme A/S? Suggest a correction